SensArs coordinates a consortium of 4 partners coming from 4 countries to take to market its product SENSY, unique worldwide device to restore sensory feedback to leg amputees. The project is financed by the European Commission and is called GoSafe. More information can be found here.
SensArs, within a consortium of 6 partners coming from 5 countries, was financed from the European Commission to explore the feasibility of stimulating the vagal nerve to control the heartbeat of patients who underwent heart transplantation. The project is called NeuHearth (Grant agreement ID: 824071). More information can be found here.
SensArs is one of the 4 Startups selected for the EIT Health Germany Headstart Awards 2018 – valued at €50,000 each – to accelerate their entry to market. Read here the news from EIT Health.
Click here to view full document.
“The venture leaders Life Science program is a one-week investors and business roadshow in Boston, co-organized with swissnex Boston. This year’s winners develop amazing technologies such as a prosthesis which allows amputees to naturally feel their missing limbs again or an ingeniously simple approach to computed guided needle navigation in the body.”
“The seventh edition of the TOP 100 Swiss startup ranking was disclosed on September 6th in front of 600 participants. The broad spectrum of innovative high-tech startups attracted dozens of investors from abroad, and even from Silivon Valley and China. Switzerland ranks as the most innovative nation according to the Global Innovation Index 2017. The TOP[…]
‘Four Swiss start-ups will receive CHF 50’000 each through the Horizon 2020 SME instrument scheme. The instrument, provided with about € 3 billion, is accessible to Swiss SMEs since January 2017. Next application deadline is 6 September.’
Sensars is featured on 101 innovative digital health, eHealth, mHealth startups in Switzerland list on Science Service (Dr. Hempel Digital Health Network) website. Check out the full list here.